GST profiteering: Rs 230-crore penalty on Johnson & Johnson

The authority said it found it ‘surprising’ that the FMCG major had not added the tax cost and losses to prices of products between July 1 and November 14, 2017, but had chosen to do so from November 15, when it was supposed to have reduced prices due to the rate reduction to 18% from 28%.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news